Vitamin a and its derivatives in experimental photocarcinogenesis: Preventive effects and relevance to humans

Journal of Drugs in Dermatology

Volumn 12, Issue 4, 2013, Pages 458-463

  Shapiro, Stanley S ^a   Seiberg, Miri ^b   Cole, Curtis A ^c  

^a Skinnovations LLC   (United States)

^b Seiberg Consulting LLC   (United States)

^c JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC; ETRETIN; ETRETINATE; INTERLEUKIN 10; ISOTRETINOIN; MELANIN; PLACEBO; RETINAL; RETINOIC ACID; RETINOID; RETINOL; RETINOL DERIVATIVE; RETINOL ESTER; RETINOL PALMITATE; SUNSCREEN; TAZAROTENE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACTINIC KERATOSIS; ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ARTICLE; BASAL CELL CARCINOMA; CANCER MODEL; CANCER PREVENTION; CANCER SIZE; CANCER SUSCEPTIBILITY; CELLULAR IMMUNODEFICIENCY; CHICK EMBRYO; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DYSKERATOSIS; EPIDERMIS; GENOTOXICITY; HAIRLESS MOUSE; HIGH RISK POPULATION; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOSUPPRESSIVE TREATMENT; KERATOACANTHOMA; MALIGNANT TRANSFORMATION; NON MELANOMA SKIN CANCER; NONHUMAN; OXIDATIVE STRESS; PHOTOTOXICITY; PUBLICATION; RADIATION CARCINOGENESIS; RADIATION PROTECTION; RADIOSENSITIVITY; REGULATORY T LYMPHOCYTE; RETINOL DEFICIENCY; RISK ASSESSMENT; SKIN CANCER; SKIN CARCINOGENESIS; SKIN CARE; SKIN PROTECTION; SKINFOLD THICKNESS; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL METAPLASIA; TOXICITY TESTING; ULTRAVIOLET A RADIATION; XERODERMA PIGMENTOSUM;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTICARCINOGENIC AGENTS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, HAIRLESS; NEOPLASMS, RADIATION-INDUCED; RETINOIDS; SKIN NEOPLASMS; SPECIES SPECIFICITY; ULTRAVIOLET RAYS; VITAMIN A;

EID: 84875840690     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Lotan R. Retinoids in cancer chemoprevention. FASEB J. 1996;10(9):1031-1039. (Pubitemid 26285979)
2. Shamberger RJ. Inhibitory effect of vitamin A on carcinogenesis. J Natl Cancer Inst. 1971;47(3):667-673.
3. Gensler HL, Sim DA, Bowden G T. Influence of the duration of topical 13-cisretinoic acid treatment on inhibition of mouse skin tumor promotion. Cancer Res. 1986;46(6):2767-2770. (Pubitemid 16074278)
4. Verma AK, Slaga TJ, Wertz PW, Mueller GC, Boutwell RK. Inhibition of skin tumor promotion by retinoic acid and its metabolite 5,6-epoxyretinoic acid. Cancer Res. 1980;40(7):2367-2371 (Pubitemid 10082252)
5. Verma AK, Duvick L, Ali M. Modulation of mouse skin tumor promotion by dietary 13-cis-retinoic acid and alpha-difluoromethylornithine. Carcinogenesis. 1986;7(6):1019-1023
6. Gensler HL, Watson RR, Moriguchi S, Bowden GT. Effects of dietary retinyl palmitate or 13-cis-retinoic acid on the promotion of tumors in mouse skin. Cancer Res. 1987;47(4):967-970. (Pubitemid 17027911)
7. Chen LC, Tarone R, Huynh M, De Luca LM. High dietary retinoic acid inhibits tumor promotion and malignant conversion in a two-stage skin carcinogenesis protocol using 7,12-dimethylbenz[a]anthracene as the initiator and mezerein as the tumor promoter in female SENCAR mice. Cancer Lett. 1995;95(1-2):113-118.
8. Hennings H, Wenk ML, Donahoe R. Retinoic acid promotion of papilloma formation in mouse skin. Cancer Lett. 1982;16(1):1-5. (Pubitemid 12008951)
9. Marquez C, Bair SM, Smithberger E, Cherpelis BS, Glass LF. Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients. J Drugs Dermatol. 2010;9(7):753-758.
10. Wright TI, Spencer JM, Flowers FP. Chemoprevention of nonmelanoma skin cancer. J Am Acad Dermatol. 2006;54(6):933-946.
11. Bavinck JN, Tieben LM, Van der Woude FJ, et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol. 1995;13(8):1933-1938.
12. Clouser MC, Roe DJ, Foote JA, Harris RB, Alberts DS. Dose response of retinol and isotretinoin in the prevention of nonmelanoma skin cancer recurrence. Nutr Cancer. 2010;62(8):1058-1066.
13. Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med. 1988;318(25):1633-1637.
14. Kraemer KH, DiGiovanna JJ, Peck GL. Chemoprevention of skin cancer in xeroderma pigmentosum. J Dermatol. 1992;19(11):715-718. (Pubitemid 23119632)
15. Levine N, Moon TE, Cartmel B, et al. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev. 1997;6(11):957-961. (Pubitemid 27481645)
16. McKenna DB, Murphy GM. Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin. Br J Dermatol. 1999;140(4):656-660. (Pubitemid 29191384)
17. Moon TE, Levine N, Cartmel B, et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev. 1997;6(11):949-956. (Pubitemid 27481644)
18. Tangrea JA, Edwards BK, Taylor PR, et al. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group. J Natl Cancer Inst. 1992;84(5):328-332.
19. Bollag W, Ott F. Retinoic acid: topical treatment of senile or actinic keratoses and basal cell carcinomas. Agents Actions. 1970;1(4):172-175
20. Bollag W, Ott F. Vitamin A acid in benign and malignant epithelial tumours of the skin. Acta Derm Venereol Suppl (Stockh). 1975;74:163-166.
21. Purcell SM, Pierce DK, Dixon SL, Spielvogel RL. Chemoprevention of actinic keratoses with topical all-trans-retinoic acid [abstract]. J Invest Dermatol. 1986;86:501
22. Robinson TA, Kligman AM. Treatment of solar keratoses of the extremities with retinoic acid and 5-fluorouracil. Br J Dermatol. 1975;92(6):703-706.
23. Grupper CH, BeTrrhetti B. Cutanenotus neoplassia and etretinate. In: Stpioitzkyim KH, Karrer K, eds. Proceedings of the 13th International Congress of Chemotheraphy. Vienna, Austria: B.H. Egermann; 1983:24-27
24. Bianchi L, Orlandi A, Campione E, et al. Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases. Br J Dermatol. 2004;151(1):148-156. (Pubitemid 39061292)
25. Campanelli A, Naldi L. A retrospective study of the effect of long-term topical application of retinaldehyde (0.05%) on the development of actinic keratosis. Dermatology. 2002;205(2):146-152
26. Goodman GE. Phase II trial of retinol in patients with advanced cancer. Cancer Treat Rep. 1986;70(8):1023-1024. (Pubitemid 16041866)
27. Halpern AC, Schuchter LM, Elder DE, et al. Effects of topical tretinoin on dysplastic nevi. J Clin Oncol. 1994;12(5):1028-1035. (Pubitemid 24145333)
28. Levine N, Meyskens FL. Topical vitamin-A-acid therapy for cutaneous meta-static melanoma. Lancet. 1980;2(8188):224-226. (Pubitemid 10084825)
29. Meyskens FL Jr, Edwards L, Levine NS. Role of topical tretinoin in melanoma and dysplastic nevi. J Am Acad Dermatol. 1986;15(4 Pt 2):822-825. (Pubitemid 17170787)
30. Weinstock MA, Bingham SF, Digiovanna JJ, et al; Veterans Affairs Topical Tretinoin Chemoprevention Trial Group. Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial. J Invest Dermatol. 2012;132(6):1583-1590.
31. Brendler-Schwaab S, Czich A, Epe B, et al. Photochemical genotoxicity: principles and test methods. Report of a GUM task force. Mutat Res. 2004;566(1):65-91 (Pubitemid 38045589)
32. de Gruijl FR, Sterenborg HJ, Forbes PD, et al. Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice. Cancer Res. 1993;53(1):53-60. (Pubitemid 23019376)
33. Drobetsky EA, Turcotte J, Châteauneuf A. A role for ultraviolet A in solar mutagenesis. Proc Natl Acad Sci U S A. 1995;92(6):2350-2354.
34. Kamiya H. Mutagenic potentials of damaged nucleic acids produced by reactive oxygen/nitrogen species: approaches using synthetic oligonucleotides and nucleotides: survey and summary. Nucleic Acids Res. 2003;31(2):517-531. (Pubitemid 36175941)
35. Phillipson RP, Tobi SE, Morris JA, McMillan TJ. UV-A induces persistent genomic instability in human keratinocytes through an oxidative stress mechanism. Free Radic Biol Med. 2002;32(5):474-480 (Pubitemid 34178356)
36. Cherng SH, Xia Q, Blankenship LR, et al. Photodecomposition of retinyl palmitate in ethanol by UVA light-formation of photodecomposition products, reactive oxygen species, and lipid peroxides. Chem Res Toxicol. 2005;18(2):129-138. (Pubitemid 40256230)
37. Moan J, Porojnicu AC, Dahlback A. Ultraviolet radiation and malignant melanoma. Adv Exp Med Biol. 2008;624:104-116.
38. Swerdlow AJ, English JS, MacKie RM, et al. Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanoma. BMJ. 1988;297(6649):647-650.
39. Walter SD, Marrett LD, From L, Hertzman C, Shannon HS, Roy P. The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol. 1990;131(2):232-243
40. Westerdahl J, Ingvar C, Måsbäck A, Jonsson N, Olsson H. Risk of cutaneous malignant melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity. Br J Cancer. 2000;82(9):1593-1599. (Pubitemid 30204368)
41. Mei N, Xia Q, Chen L, Moore MM, Fu PP, Chen T. Photomutagenicity of retinyl palmitate by ultraviolet a irradiation in mouse lymphoma cells. Toxicol Sci. 2005;88(1):142-149 (Pubitemid 41548756)
42. Harrington-Brock K, Collard DD, Chen T. Bromate induces loss of heterozygosity in the thymidine kinase gene of L5178Y/Tk(+/-)-3.72C mouse lymphoma cells. Mutat Res. 2003;537(1):21-28. (Pubitemid 36556260)
43. Rothfuss A, Merk O, Radermacher P, Speit G. Evaluation of mutagenic effects of hyperbaric oxygen (HBO) in vitro. II. Induction of oxidative DNA damage and mutations in the mouse lymphoma assay. Mutat Res. 2000;471(1-2):87-94.
44. Takeuchi T, Matsugo S, Morimoto K. Mutagenicity of oxidative DNA damage in Chinese hamster V79 cells. Carcinogenesis. 1997;18(11):2051-2055 (Pubitemid 28134728)
45. an J, Xia Q, Cherng SH, et al. Photo-induced DNA damage and photocytotoxicity of retinyl palmitate and its photodecomposition products. Toxicol Ind Health. 2005;21(7-8):167-175 (Pubitemid 41152948)
46. Dufour EK, Whitwell J, Nohynek GJ, Kirkland D, Toutain H. Retinyl palmitate is non-genotoxic in Chinese hamster ovary cells in the dark or after pre-irradiation or simultaneous irradiation with UV light. Mutat Res. 2009;672(1):21-26
47. Note for Guidance on Photosafety Testing. European Agency for the Evaluation of Medicinal Products (EMEA), Committee for Proprietary Medicinal Products (CPMC). June 27, 2002
48. Gocke E, Müller L, Guzzie PJ, et al. Considerations on photochemica genotoxicity: report of the International Workshop on Genotoxicity Test Procedures Working Group. Environ Mol Mutagen. 2000;35(3):173-184 (Pubitemid 30196661)
49. Mei N, Xia Q, Chen L, Moore MM, Chen T, Fu PP. Photomutagenicity of anhydroretinol and 5,6-epoxyretinyl palmitate in mouse lymphoma cells. Chem. Res Toxicol. 2006;19(11):1435-1440. (Pubitemid 44863485)
50. Struwe M, Greulich KO, Suter W, Plappert-Helbig U. The photo comet assay be a fast screening assay for the de itt ermination of photogenotoxicity in vitro. Mutat Res. 2007;632(1-2):44-57 (Pubitemid 47031689)
51. Dufour EK, Kumaravel T, Nohynek GJ, Kirkland D, Toutain H. Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: Genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells. Mutat Res. 2006;607(2):215-224 (Pubitemid 44131516)